Simulations to assess the propagation of the impact of genetic polymorphism in CYP enzymes into PK and PD outcomes: Warfarin and dextromethorphan as examples

Author(s): G. L. Dickinson, M. S. Lennard, G. T. Turner, A. Rostami-Hodjegan
Year:

Learn More LinkedIn Twitter Facebook Email